• Home
  • Products
    • OhmX Analyzer™
        • • OhmX Sample Prep Kit
        • • OhmX-8 Detector
        • • OhmX Cartridges
        • • Human Chromosome Explorer™
  • Learn
      • Electronic Genome Mapping
      • Sample Preparation
      • Electronic Nanodetectors
      • Informatics
  • Applications
    • Functional Genomics Research
    • Clinical Research
      • Rare Disease
      • Cancer Research
    • Precision Medicine
      • Cell and Gene Therapy
      • Pharmacogenomics
    • Emerging Technologies
  • Company
      • About Us
      • Team
      • Contact Us
  • Resources
      • News
      • Publications
      • SV Discovery Grant
  • Search
  • Menu Menu

HD-Mapping Systems Shipping to Customers

October 15, 2020

Nabsys is now shipping HD-Mapping systems in fulfillment of customer orders.

HD-Mapping provides high-resolution, high-definition electronic detection that supports a variety of genomic mapping applications, across a wide range of organisms.

For product information, availability, and pricing please contact us at info@Nabsys.com.

Learn more about High-Definition whole-genome mapping at www.Nabsys.com

3 HD-Mapping systems shipping to customer labs

https://nabsys.com/wpr/wp-content/uploads/2020/10/news-Shipping-to-customers.jpg 480 800 Radar https://nabsys.com/wpr/wp-content/uploads/2023/09/Grad_White.svg Radar2020-10-15 12:40:382023-10-17 16:06:46HD-Mapping Systems Shipping to Customers

Latest News

  • Nabsys closes expanded $38M equity roundNovember 9, 2022 - 1:57 pm
  • Nabsys reveals new details about their next generation whole-genome mapping technology and partnership with Hitachi High-TechOctober 21, 2022 - 9:38 am
  • Justin Bingham Joins Nabsys as Chief Commercial OfficerOctober 19, 2022 - 8:14 am
  • Nabsys Raises $25 Million Equity RoundApril 13, 2022 - 9:00 am
  • Nabsys Releases New Nanodetector Chips, Increasing Throughput of its HD-Mapping PlatformAugust 11, 2021 - 8:00 am

60 Clifford Street
Providence, Rhode Island
02903 USA

Phone: 401.276.9100
Fax: 401.276.9122
info@nabsys.com

  • linkedin

Advance the understanding of disease, increase diagnostic yield, and improve patient outcomes by enabling routine, accurate, cost-effective analysis of genomic structural variation

Copyright © Nabsys   |   Privacy Policy   |   Terms of Use   |   Site By Radar Media
Nabsys Raises $21 Million Equity Round Led by Hitachi High-TechnologiesNabsys Releases New Nanodetector Chips, Increasing Throughput of its HD-Mapping...
Scroll to top